Hispanic residents have long been among the least likely to have health insurance — in Colorado and across the country — in part because of unauthorized immigrants. The state is expanding coverage to some of them, although the change runs up against lingering fears about the use of public benefits.
Approved as a device, not a drug, Plenity contains a plant-based gel that swells to fill 25% of a person’s stomach, to help people eat less. Results vary widely but are modest on average.
Medical debt is most prevalent in the Southeast, where states have not expanded Medicaid and have few consumer protection laws. Now, North Carolina is considering two bills that could change that, making the state a leader in protecting patients from high medical bills.
Most of the dozen states that haven’t fully expanded eligibility for Medicaid have extended or plan to extend the postpartum coverage window for new mothers. That could mean improved maternal health, but it’s only part of the puzzle when it comes to reducing the number of preventable maternal deaths in the U.S.
The U.S. health system now produces debt on a mass scale, a new investigation shows. Patients face gut-wrenching sacrifices.
Under the Affordable Care Act, insurers cannot charge consumers for various preventive services that have been recommended by experts. But if those screenings indicate more testing is needed to determine whether something is wrong, patients may be on the hook for hundreds or even thousands of dollars for diagnostic services.
State Sen. Scott Wiener opens up about a weeklong stint in the hospital last year and what it’s like to live with Crohn’s disease. The San Francisco Democrat is pushing a bill that would require insurance companies to cover certain medications while patients appeal denials.
Despite a consensus that patients should be able to get mental health care from primary care doctors, insurance policies and financial incentives may not support that.
Gov. Gavin Newsom proposed spending $100 million to make insulin affordable to millions of people with diabetes under a new state generic drug label, CalRx. But state officials haven’t said how much the insulin will cost patients or how the state will deal with distribution and other challenges.
Some consumers who think they are signing up for Obamacare insurance find out later they actually purchased a membership to a health care sharing ministry. But regulators and online advertising sites don’t do much about it.
